DAVID GRANOVSKY

Posts Tagged ‘EYE’

Thomas Gray lived six days, but his life has lasting impact

In ALL ARTICLES, HOPE AND INSPIRATION on March 31, 2015 at 9:47 am

Thomas Gray lived six days, but his life has lasting impact

Sarah Gray reacts to research information about the donated retinas from her son, Thomas, who died at six days old in 2010. Callum, 5, Thomas´ identical twin brother, plays during the visit to the Hospital of the University of Pennsylvania.

Sarah Gray reacts to research information about the donated retinas from her son, Thomas, who died at six days old in 2010. Callum, 5, Thomas’ identical twin brother, plays during the visit to the Hospital of the University of Pennsylvania. DAVID MAIALETTI / Staff Photographer
Sarah Gray reacts to research information about the donated retinas from her son, Thomas, who died at six days old in 2010. Callum, 5, Thomas´ identical twin brother, plays during the visit to the Hospital of the University of Pennsylvania.
Gallery: Thomas Gray lived six days, but his life has lasting impact

Michael Vitez, INQUIRER STAFF WRITER

When she found out early in her pregnancy that one of her identical twins would die at birth, Sarah Gray began a five-year journey that culminated last week in Philadelphia.

She had to carry the sick baby to term in order to protect his healthy twin. And she also looked into organ and tissue donation.

“Instead of thinking of our son as a victim,” she said, “I started thinking of him as a contributor to research, to science.”

On March 23, 2010, Thomas and Callum Gray were born at Fairfax Hospital in Virginia. Callum, perfect, was five pounds, 10 ounces. Thomas, four pounds, was born without part of his brain. His mother nursed him, diapered him, cradled him.

He died after six days – five years ago on Sunday. Within hours of Thomas’ death, his eyes and liver were recovered and sent – along with umbilical cord blood from him and his brother – to researchers.But that wasn’t the end of it for Sarah Gray.

She often wondered – what became of his eyes, his blood, his liver?

The Grays had received a thank-you letter from the Washington regional transplant organization, telling them their son’s corneas had been sent to the Schepens Eye Research Institute in Boston, and his liver and the cord blood to Duke University in North Carolina.

Two years later, on a business trip to Boston, Sarah Gray called the eye institute, which is affiliated with Harvard Medical School.

“I donated my son’s eyes to your lab,” she said on the phone. “Can I come by for a tour?”

The receptionist said she had never had such a request. “I’m not sure who to transfer you to,” she said, “but don’t hang up!”

The next day, Gray met James Zieske, the institute’s senior scientist, who told her “infant eyes are worth their weight in gold,” because, being so young, they have great regenerative properties. Thomas’ corneas were used in a study that could one day help cure corneal blindness.

Thirteen more studies had cited that study. Gray felt a new emotion: pride.

Before leaving, she bought a Harvard T-shirt for Callum, and decided she was going to go with the whole family to North Carolina, where Thomas’ liver and the cord blood had been sent.

Zieske also wrote her: “Your visit helped to remind me that all the eyes we receive are an incredibly generous gift from someone who loved and cared about the person who provided the eyes. I thank you for reminding me of this.”

A few months later in 2012, the Grays went to the Duke Center for Human Genetics in Durham, N.C., where even though the twins were identical, scientists found epigenetic differences in their cord blood, research that could one day help prevent Thomas’ fatal defect, anencephaly.

Sarah Gray bought Callum a Duke T-shirt.

The couple then drove down to the road to visit Cytonet, a biotech company that had used their baby’s liver in a trial to determine the best temperature to freeze liver tissue.

Already in the nonprofit public relations field, Sarah Gray became director of marketing for the American Association of Tissue Banks.

Her mantra has become donate, donate, donate, and not just for transplant, but also for research. Even if nobody asks you – doctors are often uncomfortable when a child is dying – bring it up yourself, she says.

At a conference last summer, by coincidence, Gray learned that the Old Dominion Eye Bank in North Chesterfield, Va., had shipped Thomas’ retinas to Philadelphia.

She couldn’t believe she’d never known this. She immediately wrote to the researcher at the University of Pennsylvania who used the donation in her efforts to cure retinoblastoma, the most common form of eye cancer in children.

Two days later, Gray got a reply from Arupa Ganguly, who runs the lab and is a genetics professor at the Hospital of the University of Pennsylvania.

“It is almost impossible to obtain normal retina from a child,” Ganguly wrote. “The sample from Thomas is extremely precious for us.”

Ganguly sent Callum a Penn T-shirt.

They arranged to meet last Monday.

First, Sarah, Ross, and Callum Gray went to the National Disease Research Interchange in Center City, which Sarah Gray calls “the Match.com of science.” The interchange connects hospitals that supply organs and tissue with researchers who request it.

“This seems to have brought you a lot of peace and joy,” Bill Leinweber, the interchange’s president and CEO, told Sarah. “You’ve been such a strong advocate for research and such an eloquent spokesperson for the value of research.”

After a visit there, the Gray family went to Penn to meet Ganguly and tour her lab.

Sarah Gray saw the marbled composition book in which the receipt of retinas was logged on March 30, 2010, the 360th specimen to be received. They became “RES 360,” short for Research 360.

“Is this the log book?” she asked. “Oh, my gosh.”

Gray ran her index finger over the cursive of Jennifer Yutz, the lab manager who recorded the entry.

“Ross, look at this! Med 360!”

Her husband took a look. Callum, then 4, hugged an inflatable Godzilla as tall as he is, a gift from Ganguly, bouncing it on the lab floor.

“Wow,” Sarah Gray continued. “Can I Xerox this?”

“We have a copy for you,” Ganguly said.

Penn also gave the Grays a copy of the Fed Ex packing slip confirming arrival, which Sarah Gray said she would “treasure like a war medal.”

Thomas’ retina tissue is so rare, so precious, Ganguly and her team are still saving some of it for future research. Ganguly’s staff led Sarah Gray into the hallway, where a refrigerator, innocuous and ordinary, stood across from student lockers. Yutz unlocked it.

Inside were hundreds of 1.5 milliliter tubes – smaller than cigarette filters.

Yutz pointed to two.

“There it is,” Yutz said.

“Oh my gosh!” Gray said. She couldn’t touch them. The tubes were frozen at minus-80 degrees centigrade (minus-112 Fahrenheit).

“It’s the RNA isolated from the retina tissue,” Yutz said.

Call it what you will, that was a piece of Thomas Gray, her son.

Ross Gray has long supported his wife’s journey.

“It helped her get over the loss,” he said. “It was part of the healing process, seeing that there’s still research going on five years after. His life was worthwhile. He’s brought a lot of good to the world.”

“The way I see it,” Sarah Gray said, “our son got into Harvard, Duke, and Penn. He has a job. He is relevant to the world. I only hope my life can be as relevant.”

Read more at http://www.philly.com/philly/health/20150329_Thomas_Gray_lived_six_days__but_his_life_has_lasting_impact.html#ASIBfjvkMHBMos7Y.99

NOW YOU DON’T SEE IT- NOW YOU DO

In ALL ARTICLES, SCIENCE & STEM CELLS on July 10, 2014 at 9:39 am

Now You Don’t See it- Now You Do
Author: Sarah Hoffman

660_Mans_Eye.jpg

“Boston researchers have successfully regrown human corneal tissue – a feat that could potentially restore vision in the blind.

The achievement also marks one of the first times that scientists have constructed tissue using adult-derived human stem cells.-Researchers Regrow Corneas Using Adult Human Stem Cells’. FoxNews.com

Researchers recently made great strides in the field of regrowing human tissue– this time regrowing a human cornea using adult stem cells. This is an amazing feat. They discovered that not only is it possible to regrow a cornea using cells from the functioning eye of someone who is blind in only one eye, but they can also transplant cells from a donor and regrow that way. They tested all this on mice, but used human adult stem cells. This is pretty darn cool.

And why is this possible now? Well the original hold up was their inability to harvest a specific molecule called ABCB5, which is necessary when growing corneal tissue. These researchers discovered that a high concentration of these molecules can be found in the eyes limbus (basically the white part of your eye), which in hindsight makes perfect sense. Unfortunately these cells die when the eye goes blind, but people suffering from blindness have one good eye full of these little miracle-workers. And those with blindness in both eyes can receive a transplant, though they may need immune-suppression.

These leaves only one obvious question to be answered– do these mice see as mice see? Or do they now see as us humans do? Philosophical input is welcome…

A SIGHT FOR SORE EYES

In ALL ARTICLES, SCIENCE & STEM CELLS, STEM CELLS IN THE NEWS on June 28, 2014 at 1:45 pm

20140628-143215-52335093.jpg
A Sight for Sore Eyes
Author: Sarah Hoffman

“Researchers have grown part of an eye in a lab dish, using a type of stem cell made from a piece of skin.

They said the little retina started growing and developing on its own — an important step towards creating custom-tailored organs in the lab.”

Earlier this month scientists successfully created a functioning human retina using iPSCs (induced pluripotent stem cells). But that’s not the cool part. What’s actually amazing is that they did very little to make this happen.

Wait what?! Ok let me explain. These researchers took some of these cells from a tiny little piece of human skin, basically rewound time as far as these cells are concerned and pushed them back to a more-or-less embryonic state, sent signals to some genes manipulating them to form a retina, and then let it do it’s thing. And it was a success! This little retina is living in a dish just sensing light and being a badass little organ. Even the scientists didn’t realize this would happen so naturally

BENNY HILL IS ALIVE AND WELL AS BRITAIN GOES BLIND

In ALL ARTICLES on September 23, 2011 at 7:00 am

Remember in the final scene of every episode of Benny Hill where he does something really scandalous and then gets chased by the entire cast around and around in circles?  Turns out, Benny Hill is ALIVE AND WELL and advising Britain on their medical protocols!  https://i1.wp.com/www.webtvwire.com/wp-content/uploads/2010/06/the-benny-hill-show-logo.jpg

You see, Britain, like the USA, is chasing this fleet footed “embryonic stem cell treatment comedy of errors” around and around in circles just like in the Benny Hill episodes.  Every week, the same scene is played out with Benny running, the entire cast chasing and he never gets caught.  So in Art, so in life.  Britain is chasing embryonic stem cells used for treatment of optic diseases.  And remember…

  • Embryonic stem cells STILL have ZERO successful clinical trials
  • Embryonic stem cells STILL cause cysts and tumors that can become cancerous (wait 20 years and ask again though)
  • Embryonic stem cells STILL have rejection issues that require immunosuppressive drugs
  • Embryonic stem cells STILL carry the genetic anomalies of the donor
ON THE OTHER HAND…

So on top of wasting time chasing a cure with no prior history of success and huge negative side effects, thy are running right past a treatment with a huge history of success and safety and trials.

So cue up the cameras, get everyone in costume and let’s start that famous music going as everyone chases embryonic stem cell treatments around and around.  Wait! STOP! Hold it! CUT!

How on earth can we explain the entire medical community and government running right past what already works?  Got it! Give them all blindfolds!  That way they can be assured to miss the forest but they will hit every damn tree in it and so will the patients, patiently waiting for treatments which will never come!

…annndddd   ACTION!!!

Iris of a human eye

First trial of embryonic stem cell treatment in Europe gets green light

Patients in Britain with an eye disease that leads to blindness will take part in Europe’s first human embryonic stem cell trial

British surgeons are to take part in the first trial in patients of a human embryonic stem cell therapy to gain approval from regulators in Europe.

Surgeons at Moorfields Eye Hospital in London will inject cells into the eyes of 12 patients with an incurable eye disease called Stargardt’s macular dystrophy, one of the main causes of blindness in young people…

Read more

14-month old can see, thanks to stem cells

In ALL ARTICLES on September 13, 2011 at 1:01 pm

JAMES WOODCOCK/Gazette Staff – Kaile Milton plays with her 14-month-old daughter, Skylie. Skylie recently had stem cell surgery in China to correct blindness caused by septo-optic dysplasia. Skylie and her family spent 28 days in China for her treatment.

Skylie Milton’s grandma held out a cracker while standing on the other side of the room.

“Come on, Skylie, come get a cracker,” she said.

The 14-month-old Billings girl whipped her head around, smiled from ear to ear and hobbled across the living room toward the snack.

Once Skylie got within its grasp, she reached out, took the cracker and brought it to her mouth.

It’s something she couldn’t have done just a few months ago when she could see only about a foot away.

Thanks to stem cell research, and $40,000 raised by the community to send Skylie to China for stem cell injections, the giggling girl can now see just beyond 25 feet.

“It’s just amazing, it’s awesome,” said Skylie’s mom, Kaile Milton.

Lying beside Skylie on the floor as she played with blocks, Milton still seemed to not believe her girl could see.

The doctors in China shared her amazement, Milton said.

“They were surprised she took to it so well,” Milton said. “Usually they don’t see that much progress that quickly.”

Because the type of stem cell therapy the family settled on is considered experimental in the United States, the family had trouble finding a doctor in the area who would support them. It was further research that led them to China.

Skylie received seven stem cell injections geared toward improving the her eyesight.

Skylie was born missing her septum pellucidum, the part of the brain that separates the right and left hemispheres. Without it, her optic nerves never fully developed, diminishing her eyesight.

In addition, doctors determined that Skylie suffers from septo-optic dysplasia, which affects both her eyesight and the hormones related to the pituitary gland. It affects about 1 in 10,000 births, according to the National Library of Medicine.

To improve their daughter’s eyesight, the Miltons settled on stem cell injections and then looked to the community for help. The response was overwhelming.

The person who stands out the most to Milton’s mind is Dana Lariviere of Billings, who volunteered to head a fundraiser that helped raise more than $11,000.

“We wouldn’t have made the trip without them all,” Milton said.

In China

The family was able to stay in a room at the hospital, putting them close to Skylie during her 28 days abroad.

Most of the injections were given through her arm, though a few had to be given through her head.

“Watching the IV was horrible,” Milton said. “One day they had to poke her seven times, then eventually just had to put it in her head. But she took to it really well.”

To help soothe the child, the doctors would sing her “Old MacDonald” — in Chinese.

When she wasn’t receiving an injection, Skylie was undergoing rehabilitation treatments to help keep her blood flowing and the stem cells stimulated, including acupressure, electrical stimulation, walking training and cup therapy five times a week.

To continue her progress, Milton said they make sure to massage around her eyes and her head.

It’s unknown whether Skylie will need additional stem cell injections through the procedure, which is not available in the United States.

Not alone

During Skylie’s treatment, the Miltons met two other couples going through the same procedure, both from the United States.

When they weren’t waiting in the hospital, the group was able to go into the city and take in the culture.

It was quite a shock, especially seeing strangers’ adoration for Skylie.

“We couldn’t even go to the store, it would take an hour to get down the aisle,” said Rel, the grandmother. “People were taking pictures with her.

“They were very warm and loving toward her; we couldn’t keep her away from everyone.”

Suffering from jet lag and exhausted from the daily procedures, the family mostly stuck to the hotel, watching movies and having pizza — and McDonalds — delivered to the room.

“It was definitely close quarters,” Rel said. “You don’t get to venture off too much by yourself.”

Coming home

Skylie came home on Aug. 1, and not a moment too soon. The last few weeks of treatment were miserable.

It wasn’t because of the injections. Skylie was teething.

“She was not feeling good at all,” Milton said. “She was cranky.”

Now when she is fussy, all Milton has to do is start counting, holding up her fingers for her daughter to see.

Her crying calms down and changes to laughter as she starts clapping her hands, gets up and moves on to her next adventure.

SCOTLAND JUMPS INTO STEM CELL CLINICAL TRIALS

In ALL ARTICLES on July 29, 2010 at 12:11 pm

This video shows the Health Minister of Scotland discussing current stem clinical trials in Scotland for stroke and for eye repair.  It’s significant that they are in the stem cell game.  One more country recognizing the power of stem cells.

p.s.  It’s a short video and armed with my explanation above, you probably know everything you need to know without even watching it – http://video.forbes.com/fvn/tech/scotland-stem-cell-edge

 

And now for your viewing pleasure…a pic of Cuillin Mountains in Scotland

https://i2.wp.com/www.1adventure.com/archives/images/cuillin-mountains-scotland-backside.jpg

Other STROKE articles:

  1. https://repairstemcell.wordpress.com/2010/09/21/autologous-neural-stem-cells-benefit-parkinson%e2%80%99s-patients-adultstemcell-com/
  2. https://repairstemcell.wordpress.com/2010/09/20/stem-cell-treatment-for-stroke-and-traumatic-brain-injury-wholewellness-net/
  3. http://www.scientificamerican.com/article.cfm?id=can-stem-cells-block-stroke-damage
  4. http://www.sciencedaily.com/releases/2011/08/110831160216.htm

CHEMICALLY BURNED EYES REPAIRED WITH STEM CELLS

In VICTORIES & SUCCESS STORIES on June 24, 2010 at 12:47 pm

BRIEF SUMMARY OF METHODS

  1. used autologous limbal stem cells cultivated on fibrin
  2. treated 112 patients with corneal damage
  3. most had burn-dependent limbal stem-cell deficiency

BRIEF SUMMARY OF RESULTS

  1. Permanent restoration of a transparent, renewing corneal epithelium was attained in 76.6% of eyes.
  2. Restored eyes remained stable over time, with up to 10 years of follow-up (mean, 2.91±1.99; median, 1.93).
  3. Cultures in which p63-bright cells constituted more than 3% of the total number of clonogenic cells were associated with successful transplantation in 78% of patients.

—————————————-

MORE DETAILED INFORMATION:

https://i1.wp.com/content.nejm.org/content/vol0/issue2010/images/large/NEJMoa0905955f3.jpeg

Figure 3. Regeneration of a Functional Corneal Epithelium and Restoration of Visual Acuity.

[Brief: “All three eyes had total limbal stem-cell deficiency, complete corneal opacification, and stromal scarring (images at left).  In all three patients, autologous limbal stem-cell cultures successfully regenerated functional corneal epithelium.“]

Panel A shows the left eye of Patient 93 (see Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org), who had total limbal stem-cell deficiency due to an acid burn (image at left). His visual acuity was reduced to counting fingers. A graft of autologous limbal cultures was sufficient to regenerate functional corneal epithelium (image at right) and to restore normal vision (visual acuity, 0.7), since the eye had no stromal scarring. Panel B shows the eyes of Patients 22, 26, and 46 (see Table 1 in the Supplementary Appendix), which were damaged by alkali burns and were treated with unsuccessful surgery 13, 30, and 3 years before admission, respectively. All three eyes had total limbal stem-cell deficiency, complete corneal opacification, and stromal scarring (images at left). Vision was reduced to counting fingers (in Patient 22) or perceiving hand movements (in Patients 26 and 46). In all three patients, autologous limbal stem-cell cultures successfully regenerated functional corneal epithelium. To improve their visual acuity after grafting, the patients underwent penetrating keratoplasty. In all three eyes, the engrafted limbal stem cells resurfaced the donor stroma. At the last follow-up visits (at 6, 6.5, and 4 years, respectively), all eyes were covered by stable corneal epithelium (images at right). The keratoplasty resulted in complete restoration of visual acuity in Patients 22 and 46 (0.9 and 0.8, respectively). The visual acuity of Patient 26 increased to only 0.3 because of a concomitant amblyopia (the alkali burn had occurred 30 years before admission). In Patient 46, the follow-up image shows that the conjunctival vessels stop at the conjunctival–corneal boundary (arrowheads); they do not invade the restored corneal surface.

https://i1.wp.com/content.nejm.org/content/vol0/issue2010/images/large/NEJMoa0905955f1.jpeg

Figure 1. Kaplan–Meier Estimates of Grafted Limbal Stem-Cell Survival.

[Brief: “the final clinical outcome was deemed a success in 76.6% of the eyes treated“]

Panel A shows the survival estimates for the cultures after one graft was placed, with partial or total success attained in 68.2% of the eyes treated. Panel B shows survival estimates after a second graft was placed in 11 eyes (a total of 12 additional grafts, since 1 eye was regrafted twice), indicating either partial success or failure. After regrafting, 9 of these eyes regenerated normal epithelium. Thus, the final clinical outcome was deemed a success in 76.6% of the eyes treated. All failures occurred within the first year after grafting, whereas successful cultures remained stable for up to 10 years of follow-up.

THIS POST IS AN ADDENDUM TO EARLIER STORY:  Stem Cells From Own Eyes Restore Vision to Blinded Patients, Study Shows – Bloomberg – VIA

THE IMAGES AND TEXT ARE VIA: http://content.nejm.org/cgi/content/full/NEJMoa0905955v1#F3

Stem Cells From Own Eyes Restore Vision to Blinded Patients, Study Shows – Bloomberg

In VICTORIES & SUCCESS STORIES on June 22, 2010 at 3:00 am

Stem Cells From Own Eyes Restore Vision to Blinded Patients, Study Shows

Patients blinded in one or both eyes by chemical burns regained their vision after healthy stem cells were extracted from their eyes and reimplanted, according to a report by Italian researchers at a scientific meeting.

Patient's Own Stem Cells Fix Damaged Eyes

The tissue was drawn from the limbus, an area at the junction of the cornea and white part of the eye. It was grown on a fibrous tissue, then layered onto the damaged eyes. The cells grew into healthy corneal tissue, transforming disfigured, opaque eyes into functioning ones with normal appearance and color, said researchers led by Graziella Pellegrini of the University of Modena’s Center for Regenerative Medicine.

The stem-cell treatment restored sight to more than three- quarters of the 112 patients treated, Pellegrini said yesterday in a presentation at the International Society for Stem Cell Research meeting. She estimated the work may benefit 1,000 to 2,000 patients in Europe whose eyes have been damaged by chemical burns and many more in developing countries where the use of chemicals is less regulated. Her patients were followed for an average of three years and some for as long as a decade…..

via Stem Cells From Own Eyes Restore Vision to Blinded Patients, Study Shows – Bloomberg.

Charlestown boy’s sight improves after stem cell treatment

In VICTORIES & SUCCESS STORIES on May 25, 2010 at 10:00 am

IMPROVEMENT: Connor Wink, 11, and his mother Tracey.

Charlestown boy’s sight improves after stem cell treatment

BY DONNA SHARPE – 18 May, 2010 10:44 AM

A CHARLESTOWN boy is showing marked signs of improvement in sight after his first round of stem cell treatment.

Connor Wink, 11, and his mother Tracey recently returned from China where he received a round of injections, which are not available in Australia.

The treatment appears to have had dramatic results.

Connor has gained light perception, a sign the treatment is working.

Born blind, he also suffers nystagmus, a condition which means Connor has poor muscle control causing his eyes to move frequently.

“That has slowed right down so it’s certainly a big plus,” Mrs Wink said.

Connor is the second Hunter child to undergo stem cell treatment in China.

Holly Arvidson, 12, of Denman, is having a second round of the procedure in a bid to restore her sight.

For the past 12 months, The Herald has been following the progress of Holly, who is in China with her family for the treatment which involves stem cell injections, acupuncture and bone marrow cultivation.

The treatment is only available in a handful of hospitals worldwide. It has an 80 per cent success rate but since Holly’s first round her condition has not changed.

Mrs Wink said she is praying Holly receives a positive result this time.

“Connor was lucky and we have seen improvements. We were sitting in front of a fire at the weekend and he could tell when someone was putting logs on it,” she said.

The Charlestown community and Connor’s school, Hillsborough Public, helped raise money for the China trip.

“We still have enough money to travel for Connor’s second round of treatment thanks to those earlier fund-raising efforts which Connor was a big part of, raising $6000 busking.”

via Charlestown boy’s sight improves after stem cell treatment – Local News – News – General – The Herald.

The Ray Romano + Kevin James Celebrity Golf Classic to Benefit Advancement in Vision Research

In VICTORIES & SUCCESS STORIES on October 2, 2009 at 8:49 pm

The Ray Romano and Kevin James Celebrity Golf Classic to Benefit Advancement in Vision Research

https://i1.wp.com/blogs.ajc.com/radio-tv-talk/files/2009/04/aug2006-ray_romano.jpgLA JOLLA, Calif.–(BUSINESS WIRE)–The Ray Romano and Kevin James Celebrity Golf Classic will be held on Monday, November 16, 2009 at the El Caballero Country Club in Tarzana, California. This year’s golf classic will benefit the advancement in vision science at The Scripps Research Institute in La Jolla, California.

The celebrity tournament is an annual event hosted by television and film stars Ray Romano (Everybody Loves Raymond, Ice Age) and Kevin James (The King of Queens, Paul Blart: Mall Cop). Each year, Romano and James choose a cause to support that is close to their hearts. Funds raised by this year’s golf tournament will support the research and treating of such debilitating vision diseases as retinitis pigmentosa and macular degeneration.

“My scientific team and I greatly appreciate Ray and Kevin for choosing The Scripps Research Institute as the beneficiary of this year’s golf tournament. The Ray Romano & Kevin James Celebrity Golf Classic’s contribution will be dedicated to research on stem cells for RP and MD patients,” said Scripps Research Professor Martin Friedlander, M.D./Ph.D., who is also a practicing ophthalmologist at the Scripps Clinic.

via The Ray Romano and Kevin James Celebrity Golf Classic to Benefit Advancement in Vision Research.

Follow

Get every new post delivered to your Inbox.

Join 3,364 other followers

%d bloggers like this: